Assessment of Efficacy of AZD2281 in Platinum Sensitive Relapsed Serous Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mika Sovak, BSc, MBCHB, MD
AstraZeneca
Study Director - Prof Jonathan A Lederman
University College, London
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
107 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Adelaide, Australia
- Research Site
East Bentleigh, Australia
- Research Site
Heidelberg, Australia
- Research Site
Melbourne, Australia
- Research Site
Nambour, Australia
- Research Site
Randwick, Australia
- Research Site
South Brisbane, Australia
- Research Site
Toorak Gardens, Australia
- Research Site
Innsbruck, Austria
- Research Site
Vienna, Austria
- Research Site
Wein, Austria
- Research Site
Brussels, Belgium
- Research Site
Leuven, Belgium
- Research Site
Vancouver, British Columbia, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Sherbrooke, Quebec, Canada
- Research Site
Brno, Czechia
- Research Site
Brno, Czechia
- Research Site
Olomouc, Czechia
- Research Site
Prague, Czechia
- Research Site
Tallinn, Estonia
- Research Site
Tartu, Estonia
- Research Site
Bordeaux, France
- Research Site
Caen, France
- Research Site
Lyon, France
- Research Site
Nantes, France
- Research Site
Paris, France
- Research Site
Paris, France
- Research Site
Reims, France
- Research Site
Bonn, Germany
- Research Site
Düsseldorf, Germany
- Research Site
Essen, Germany
- Research Site
Freiburg im Breisgau, Germany
- Research Site
Göttingen, Germany
- Research Site
Hanover, Germany
- Research Site
Kiel, Germany
- Research Site
Marburg, Germany
- Research Site
München, Germany
- Research Site
Rostock, Germany
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Aug 2008
- Primary completion
- 30 Jun 2010
- Completion
- 12 Oct 2023
- Last update posted
- 3 Feb 2025
- Registered enrollment
- 265
- Registry id
- NCT00753545
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.